Protagonist Therapeutics Inc (PTGX)
30.74
-1.20
(-3.76%)
USD |
NASDAQ |
May 17, 16:00
30.74
0.00 (0.00%)
Pre-Market: 20:00
Protagonist Therapeutics Accounts Payable (Quarterly): 3.507M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.507M |
| December 31, 2023 | 0.772M |
| September 30, 2023 | 1.252M |
| June 30, 2023 | 4.573M |
| March 31, 2023 | 4.021M |
| December 31, 2022 | 3.64M |
| September 30, 2022 | 4.715M |
| June 30, 2022 | 1.412M |
| March 31, 2022 | 7.159M |
| December 31, 2021 | 1.60M |
| September 30, 2021 | 0.706M |
| June 30, 2021 | 7.905M |
| March 31, 2021 | 2.732M |
| December 31, 2020 | 3.075M |
| September 30, 2020 | 2.797M |
| June 30, 2020 | 2.855M |
| March 31, 2020 | 3.704M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.79M |
| September 30, 2019 | 1.583M |
| June 30, 2019 | 2.787M |
| March 31, 2019 | 6.454M |
| December 31, 2018 | 5.711M |
| September 30, 2018 | 4.871M |
| June 30, 2018 | 2.278M |
| March 31, 2018 | 1.307M |
| December 31, 2017 | 1.257M |
| September 30, 2017 | 2.267M |
| June 30, 2017 | 2.639M |
| March 31, 2017 | 1.132M |
| December 31, 2016 | 1.163M |
| September 30, 2016 | 2.335M |
| June 30, 2016 | 1.441M |
| March 31, 2016 | 1.89M |
| December 31, 2015 | 1.247M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.706M
Minimum
Sep 2021
7.905M
Maximum
Jun 2021
3.179M
Average
2.826M
Median
Accounts Payable (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 22.14M |
| SELLAS Life Sciences Group Inc | 7.407M |
| Akebia Therapeutics Inc | 11.88M |
| Immuneering Corp | 2.271M |
| Moderna Inc | 183.00M |